A notable problem with implementation of TNF-α as a routine diagnostic biomarker is its undetectable serum level in a significant percentage of patients with a proven Gram-positive bacterial infection of moderate disease severity [12]. The gene discussed is TNF; the disease is gram-positive bacterial infections.